HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Divino, C. M. Articles by Schussler, G. C. Search for Related Content PubMed PubMed Citation Articles by Divino, C. M. Articles by Schussler, G. C. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 265, Issue 3, 1425-1429, 01, 1990

Receptor-mediated uptake and internalization of transthyretin

CM Divino and GC Schussler
Department of Medicine, State University of New York Health Science Center, Brooklyn 11203.

Evidence of cellular transthyretin (TTR) binding was sought because of the observation that transthyretin can increase the uptake of its hormonal ligand. Transthyretin was bound by human hepatoma (Hep G2) cells in a time- and temperature-dependent manner, reaching equilibrium within 2 h. Scatchard analysis was consistent with a single class of high affinity binding sites with a Kd of approximately 5 nM at 0 and 4 degrees C and 14 nM at 37 degrees C. These dissociation constants are more than 2 orders of magnitude lower than the concentration of transthyretin in human serum. The apparent capacity at 0 degrees C, corrected for internalized TTR, was approximately 20,000 sites/cell. Saturable, high affinity binding of human transthyretin was also demonstrable with rat primary hepatocytes and human renal adenocarcinoma, neuroblastoma, and transformed lung cells. Rat and human transthyretin were equipotent in displacing isotopically labeled, species-specific transthyretin from human hepatoma cells and rat primary hepatocytes, a finding that is consistent with the strong homology between rat and human transthyretin. Eighty-eight percent of the saturable uptake was internalized as determined by proteolytic removal of surface transthyretin. Internalization was dependent on receptor binding and was more markedly inhibited than surface binding at 0 degrees C. Concentrations of thyroxine within a range that saturated a significant proportion of the primary and secondary TTR iodothyronine binding sites increased the uptake and internalization of transthyretin in a dose-dependent manner. By analogy to the function of receptors for other transport proteins, the interaction between transthyretin and its receptor is likely to affect ligand delivery and may have additional metabolic effects.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. E. Steward, R. S. Armen, and V. Daggett Different disease-causing mutations in transthyretin trigger the same conformational conversion Protein Eng. Des. Sel., March 1, 2008; 21(3): 187 - 195. [Abstract] [Full Text] [PDF]

				N. A. Kassem, R. Deane, M. B. Segal, and J. E. Preston Role of transthyretin in thyroxine transfer from cerebrospinal fluid to brain and choroid plexus Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1310 - R1315. [Abstract] [Full Text] [PDF]

				A. Lim, T. Prokaeva, M. E. McComb, L. H. Connors, M. Skinner, and C. E. Costello Identification of S-sulfonation and S-thiolation of a novel transthyretin Phe33Cys variant from a patient diagnosed with familial transthyretin amyloidosis Protein Sci., August 1, 2003; 12(8): 1775 - 1785. [Abstract] [Full Text] [PDF]

				O. E. Janssen, H. M. B. Golcher, H. Grasberger, B. Saller, K. Mann, and S. Refetoff Characterization of T4-Binding Globulin Cleaved by Human Leukocyte Elastase J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1217 - 1222. [Abstract] [Full Text] [PDF]

				J. H. Oppenheimer and H. L. Schwartz Molecular Basis of Thyroid Hormone-Dependent Brain Development Endocr. Rev., August 1, 1997; 18(4): 462 - 475. [Abstract] [Full Text] [PDF]

				A. V. Vieira, E. J. Sanders, and W. J. Schneider Transport of Serum Transthyretin into Chicken Oocytes J. Biol. Chem., February 17, 1995; 270(7): 2952 - 2956. [Abstract] [Full Text] [PDF]

				M. M. Sousa, A. G. W. Norden, C. Jacobsen, T. E. Willnow, E. I. Christensen, R. V. Thakker, P. J. Verroust, S. K. Moestrup, and M. J. Saraiva Evidence for the Role of Megalin in Renal Uptake of Transthyretin J. Biol. Chem., December 1, 2000; 275(49): 38176 - 38181. [Abstract] [Full Text] [PDF]

				A. M. van Bennekum, S. Wei, M. V. Gamble, S. Vogel, R. Piantedosi, M. Gottesman, V. Episkopou, and W. S. Blaner Biochemical Basis for Depressed Serum Retinol Levels in Transthyretin-deficient Mice J. Biol. Chem., January 5, 2001; 276(2): 1107 - 1113. [Abstract] [Full Text] [PDF]

				M. M. Sousa and M. J. Saraiva Internalization of Transthyretin. EVIDENCE OF A NOVEL YET UNIDENTIFIED RECEPTOR-ASSOCIATED PROTEIN (RAP)-SENSITIVE RECEPTOR J. Biol. Chem., April 20, 2001; 276(17): 14420 - 14425. [Abstract] [Full Text] [PDF]